Yaoming biological suspended trading in Hong Kong
As of press time, Yaoming biology has suspended trading in Hong Kong.
This text is a result of machine translation.
Related companies：
In-depth
Briefing Mar 13, 2022 08:49 PM
· Financials
Capital group, an asset management institution, launched ETF products for the first time: buying Chinese stocks such as Guizhou Maotai, Yaoming biology and meituan
Jan 30, 2024 07:59 PM
Dec 11, 2023 08:49 PM
Jan 05, 2023 07:33 PM
Nov 16, 2022 05:19 PM
Briefing Feb 08, 2022 03:30 PM
· Healthcare
Yaoming biological was included in the "unverified list" in the United States, and its share price plummeted
Briefing Feb 07, 2022 08:09 AM
· Healthcare
The battery plant jointly built by SK innovation and Ford was started in December last year
Consumer Staples · Analysis
The Next Trillion-Dollar Market in Latin America
On April 11, the U.S. waived import tariffs on Chinese consumer electronics, highlighting China’s 3C exports. While this provides short-term relief, Latin America, with its growing population and digitalization, is poised to become the next major market for 3C brands, potentially exceeding USD 100 billion by 2028, with opportunities in Mexico, Brazil, and Argentina.
Apr 30, 2025 07:17 PM
See more
Read next
Insight
In-depth
Insight
In-depth
Automotive · Analysis
$30 Million Lost Annually in the West, Yet Chinese Enterprises Pay No Attention
Apr 30, 2025 11:14 AM
Insight
In-depth
Technology · Analysis
Auto Shanghai 2025 - Nullmax Showcases Full-Stack Automated Driving Solutions
Apr 25, 2025 11:24 PM
Insight
In-depth
Technology · Analysis
SAIC MAXUS Partners with Huawei Qiankun, Multiple Models to be Launched
Apr 25, 2025 08:41 PM